Daily or Weekly Vitamin D? The Pharmacology Says It Doesn't Matter — With One Important Exception

If you've been prescribed vitamin D, there's a good chance the script read "50,000 IU once weekly." That dosing schedule has become standard — but the reason it's written that way has more to do with prescription convenience than with how vitamin D actually behaves in the body.

The Pharmacokinetics of Vitamin D

The form of vitamin D measured on blood tests, 25-hydroxyvitamin D [25(OH)D], has a relatively long half-life in circulation — roughly 15 to 25 days. This means blood levels change slowly. After starting supplementation, it takes approximately 8 to 12 weeks to reach steady state regardless of dosing schedule.

With daily dosing, levels rise in a smooth, gradual curve as each small dose accumulates faster than it clears. With weekly dosing, a larger bolus produces a more pronounced spike that decays over the following week before the next dose arrives. The resulting curve oscillates, but the average blood level it settles at is determined by total weekly dose — not by how that dose is distributed.

The Study That Demonstrated This Directly

Ish-Shalom and colleagues (2008, J Clin Endocrinol Metab, PMID 18544622) randomised 48 elderly hip fracture patients to one of three dosing schedules with matched total doses:

  • 1,500 IU daily
  • 10,500 IU weekly
  • 45,000 IU monthly

After two months, the three groups landed at 33, 29, and 37 ng/mL respectively. No statistically significant difference between any of them. Same total dose, same destination — just different shapes getting there.

The same principle applies at standard supplementation doses. 2,000 IU daily and 14,000 IU weekly deliver identical total weekly exposure. By week 8–12, blood levels converge.

So Why Is Weekly Still the Standard Prescription?

Adherence. Patients are more likely to consistently take a single weekly pill than to remember a daily one. That's a behavioural argument, not a pharmacological one, and it's a reasonable consideration in clinical practice. If daily dosing suits your routine better, the pharmacology supports it equally well — and the result is a smoother blood level curve.

The Exception: Extreme Bolus Dosing

Matching daily and weekly schedules doesn't mean all dosing schedules are equivalent. Very large, infrequent boluses appear to carry genuine risk.

Sanders and colleagues (2010, JAMA, PMID 20460620) tested a single 500,000 IU annual bolus in 2,256 older women. Compared to placebo, the annual bolus group experienced 15% more falls (83 vs 73 per 100 person-years) and 26% more fractures (4.9 vs 3.9 per 100 person-years) over three to five years. A post-hoc analysis showed the excess falls clustered in the first three months following each annual dose — the window when blood levels had spiked above approximately 120 nmol/L (~48 ng/mL).

Weekly and monthly schedules produce far smaller oscillations than annual bolusing, but the principle is worth noting: smoother is likely safer at the extremes.

What Level Should You Be Targeting?

"Sufficient" varies considerably by the outcome you're optimising for. The Institute of Medicine sets sufficiency at 20 ng/mL. The Endocrine Society recommends 30 ng/mL or above for adults at risk of osteoporosis.

Heaney and colleagues (2003, J Am Coll Nutr, PMID 12672710) demonstrated that calcium absorption was 65% higher at 34 ng/mL than at 20 ng/mL — both within the "normal" reference range in standard lab reporting. A result within range doesn't necessarily mean a result that's optimised for the specific outcome that matters to you.

For most adults, 2,000–4,000 IU daily is sufficient to maintain levels in the 30–50 ng/mL range. Those with obesity, malabsorption conditions, or very limited sun exposure typically require more. Testing at 8–12 weeks after starting or changing a dose is the most direct way to know where you land.

The Bottom Line

Total dose drives blood levels. Dosing schedule — daily, every other day, weekly — changes the shape of the curve getting there, but not the destination. Pick the schedule you'll actually stick to, confirm your levels after 8–12 weeks, and avoid the extreme end of bolus dosing where the evidence suggests risk begins to outweigh the convenience.

References